Companion Animal Health Market Outlook 2023-2028:
IMARC Group’s latest report, titled “Companion Animal Health Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, the global companion animal health market size reached US$ 23.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 39.0 Billion by 2028, exhibiting a growth rate (CAGR) of 8.4% during 2023-2028.
Companion animal health refers to the physical and emotional well-being of dogs, cats, and other small mammals that are kept as companions. This encompasses a wide range of health concerns, from preventive care and routine check-ups to the treatment of chronic and acute illnesses. It aims to maintain physical health and mental and emotional well-being by providing adequate socialization and training and addressing behavior problems, such as separation anxiety and aggression. Additionally, it helps in providing appropriate nutrition, exercise, and a safe and clean environment and aids in offering regular veterinary check-ups and vaccinations that help prevent and control the spread of infectious diseases.
Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/companion-animal-health-market/requestsample
Competitive Landscape with Key Players:
The competitive landscape of the industry has also been examined along with the profiles of the key players being
- Agrolabo S.p.A
- Boehringer Ingelheim
- Ceva Santé Animale
- Dechra Pharmaceuticals PLC
- Elanco Animal Health Incorporated
- IDEXX Laboratories Inc
- Indian Immunologicals Limited (National Dairy Development Board)
- Merck & Co. Inc
- Norbrook Laboratories
- Vetoquinol SA
- Virbac
- Zoetis
Companion Animal Health Market Growth:
The increasing trend of pet ownership is driving the global market. Moreover, the rising incidences of chronic conditions, including obesity, diabetes, and cardiovascular diseases in pets, are catalyzing the demand for pet healthcare products and services across the globe. Along with this, the growing awareness regarding the importance of animal health and well-being among the masses is contributing to the market. Furthermore, the rising number of animal diseases is impelling major companies to develop effective drugs and vaccines is impacting the market favorably. Additionally, the introduction of advanced technologies, such as telemedicine and smart pet healthcare products, is creating a positive market outlook. Other factors, including the growing awareness regarding the availability of pet insurance and inflating disposable income levels of the masses, are projected to propel the market further.
Key Market Segmentation:
Breakup by Animal Type:
- Dogs
- Cats
- Equine
- Others
Breakup by Product:
- Vaccines
- Pharmaceuticals
- Feed Additives
- Diagnostics
- Others
Breakup by End User:
- Point-of-care Testing/In-house Testing
- Veterinary Hospitals and Clinics
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key Highlights of the Report:
- Market Performance (2017-2022)
- Market Outlook (2023-2028)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/companion-animal-health-market
Related Report by IMARC Group:
- Healthcare Predictive Analytics Market Overview 2023
- Hepatitis Diagnostic Tests Market Overview 2023
- Hereditary Angioedema Therapeutic Market Overview 2023
- Portable Medical And Healthcare Devices Market Overview 2023
- Preventive Healthcare Technologies and Services Market Overview 2023
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Media Contact
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: Send Email
Phone: +1-631-791-1145
Address:134 N 4th St.
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com